Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2884

1.

Phase III trials in ovarian cancer: The evolving landscape of front line therapy.

Naumann RW, Coleman RL, Brown J, Moore KN.

Gynecol Oncol. 2019 Feb 12. pii: S0090-8258(19)30113-1. doi: 10.1016/j.ygyno.2019.02.008. [Epub ahead of print] Review.

PMID:
30765149
2.

EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasis.

Zhao Y, Ding L, Wang D, Ye Z, He Y, Ma L, Zhu R, Pan Y, Wu Q, Pang K, Hou X, Weroha SJ, Han C, Coleman R, Coleman I, Karnes RJ, Zhang J, Nelson PS, Wang L, Huang H.

EMBO J. 2019 Feb 5. pii: e99599. doi: 10.15252/embj.201899599. [Epub ahead of print]

PMID:
30723117
3.

Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer.

Gao Q, Yang Z, Xu S, Li X, Yang X, Jin P, Liu Y, Zhou X, Zhang T, Gong C, Wei X, Liu D, Sun C, Chen G, Hu J, Meng L, Zhou J, Sawada K, Fruscio R, Grunt TW, Wischhusen J, Vargas-Hernández VM, Pothuri B, Coleman RL.

J Exp Med. 2019 Feb 1. pii: jem.20180765. doi: 10.1084/jem.20180765. [Epub ahead of print]

PMID:
30710055
4.

It takes a village: channeling fatty acid metabolism and triacylglycerol formation via protein interactomes.

Coleman RA.

J Lipid Res. 2019 Jan 25. pii: jlr.S091843. doi: 10.1194/jlr.S091843. [Epub ahead of print]

5.

Urban blue: A global analysis of the factors shaping people's perceptions of the marine environment and ecological engineering in harbours.

Strain EMA, Alexander KA, Kienker S, Morris R, Jarvis R, Coleman R, Bollard B, Firth LB, Knights AM, Grabowski JH, Airoldi L, Chan BKK, Chee SY, Cheng Z, Coutinho R, de Menezes RG, Ding M, Dong Y, Fraser CML, Gómez AG, Juanes JA, Mancuso P, Messano LVR, Naval-Xavier LPD, Scyphers S, Steinberg P, Swearer S, Valdor PF, Wong JXY, Yee J, Bishop MJ.

Sci Total Environ. 2019 Mar 25;658:1293-1305. doi: 10.1016/j.scitotenv.2018.12.285. Epub 2018 Dec 20.

PMID:
30677991
6.

Endogenous production of IL-1B by breast cancer cells drives metastasis and colonisation of the bone microenvironment.

Tulotta C, Lefley DV, Freeman K, Gregory WM, Hanby AM, Heath PR, Nutter-Howard F, Wilkinson JM, Spicer-Hadlington AR, Liu X, Bradbury S, Hambley L, Cookson V, Allocca G, Kruithof-de-Julio M, Coleman RE, Brown JE, Holen I, Ottewell PD.

Clin Cancer Res. 2019 Jan 22. pii: clincanres.2202.2018. doi: 10.1158/1078-0432.CCR-18-2202. [Epub ahead of print]

PMID:
30670488
7.

Presumed early ovarian cancer with isolated tumor cells in para-aortic sentinel nodes.

Uccella S, Fagotti A, Zannoni GF, Coleman RL.

Int J Gynecol Cancer. 2019 Jan;29(1):216-220. doi: 10.1136/ijgc-2018-000005. No abstract available.

PMID:
30640707
8.

Exploring and comparing adverse events between PARP inhibitors.

LaFargue CJ, Dal Molin GZ, Sood AK, Coleman RL.

Lancet Oncol. 2019 Jan;20(1):e15-e28. doi: 10.1016/S1470-2045(18)30786-1. Review.

PMID:
30614472
9.

Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04).

Coleman RE, Collinson M, Gregory W, Marshall H, Bell R, Dodwell D, Keane M, Gil M, Barrett-Lee P, Ritchie D, Bowman A, Liversedge V, De Boer RH, Passos-Coelho JL, O'Reilly S, Bertelli G, Joffe J, Brown JE, Wilson C, Tercero JC, Jean-Mairet J, Gomis R, Cameron D.

J Bone Oncol. 2018 Sep 27;13:123-135. doi: 10.1016/j.jbo.2018.09.008. eCollection 2018 Nov.

10.

Analysis of chain length, substitution patterns, and unsaturation of AM-404 derivatives as 20S proteasome stimulators.

Coleman RA, Muli CS, Zhao Y, Bhardwaj A, Newhouse TR, Trader DJ.

Bioorg Med Chem Lett. 2019 Feb 1;29(3):420-423. doi: 10.1016/j.bmcl.2018.12.030. Epub 2018 Dec 19.

PMID:
30587447
11.

Balancing biodiversity outcomes and pollution management in urban stormwater treatment wetlands.

Hale R, Swearer SE, Sievers M, Coleman R.

J Environ Manage. 2019 Mar 1;233:302-307. doi: 10.1016/j.jenvman.2018.12.064. Epub 2018 Dec 21.

PMID:
30583104
12.

Thioesterase superfamily member 2 promotes hepatic insulin resistance in the setting of glycerol-3-phosphate acyltransferase 1-induced steatosis.

Tillander V, Miniami A, Alves-Bezerra M, Coleman RA, Cohen DE.

J Biol Chem. 2019 Feb 8;294(6):2009-2020. doi: 10.1074/jbc.RA118.005184. Epub 2018 Dec 6.

PMID:
30523156
13.

Glycerol-3-phosphate acyltransferases 3 and 4 direct glycerolipid synthesis and affect functionality in activated macrophages.

Quiroga IY, Pellon-Maison M, Suchanek AL, Coleman RA, Gonzalez-Baro MR.

Biochem J. 2019 Jan 11;476(1):85-99. doi: 10.1042/BCJ20180381.

PMID:
30523059
14.

Using PARP Inhibitors in the Treatment of Patients With Ovarian Cancer.

Kurnit KC, Coleman RL, Westin SN.

Curr Treat Options Oncol. 2018 Nov 15;19(12):1. doi: 10.1007/s11864-018-0572-7. Review.

PMID:
30535808
15.

A randomized phase II study of letrozole vs. observation in patients with newly diagnosed uterine leiomyosarcoma (uLMS).

Slomovitz BM, Taub MC, Huang M, Levenback C, Coleman RL.

Gynecol Oncol Rep. 2018 Nov 16;27:1-4. doi: 10.1016/j.gore.2018.11.001. eCollection 2019 Feb.

17.

Salmonella enterica Serovar Typhimurium and Escherichia coli Survival in Estuarine Bank Sediments.

Siddiqee MH, Henry R, Coulthard R, Schang C, Williamson R, Coleman R, Rooney G, Deletic A, McCarthy D.

Int J Environ Res Public Health. 2018 Nov 21;15(11). pii: E2597. doi: 10.3390/ijerph15112597.

18.

Sleep Evaluation in the Assessment of Pediatric Attention Deficit Disorders.

Teague MS, Hockenberry M, Kinney JL, Coleman R.

J Pediatr Health Care. 2018 Nov 19. pii: S0891-5245(18)30220-7. doi: 10.1016/j.pedhc.2018.08.005. [Epub ahead of print]

PMID:
30466794
19.

Tubulocystic anomalies of the mesonephric duct associated with ipsilateral renal dysgenesis.

Coleman R, Sanchez O, Ghattaura H, Green K, Chandran H, McCarthy L, Parashar K.

J Pediatr Urol. 2018 Sep 6. pii: S1477-5131(18)30414-5. doi: 10.1016/j.jpurol.2018.07.021. [Epub ahead of print]

PMID:
30446299
20.

Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.

Westbrook JA, Wood SL, Cairns DA, McMahon K, Gahlaut R, Thygesen H, Shires M, Roberts S, Marshall H, Oliva MR, Dunning MJ, Hanby AM, Selby PJ, Speirs V, Mavria G, Coleman RE, Brown JE.

J Pathol. 2019 Mar;247(3):381-391. doi: 10.1002/path.5197. Epub 2019 Jan 25.

PMID:
30426503
21.

BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma.

Lin KK, Harrell MI, Oza AM, Oaknin A, Ray-Coquard I, Tinker AV, Helman E, Radke MR, Say C, Vo LT, Mann E, Isaacson JD, Maloney L, O'Malley DM, Chambers SK, Kaufmann SH, Scott CL, Konecny GE, Coleman RL, Sun JX, Giordano H, Brenton JD, Harding TC, McNeish IA, Swisher EM.

Cancer Discov. 2019 Feb;9(2):210-219. doi: 10.1158/2159-8290.CD-18-0715. Epub 2018 Nov 13.

PMID:
30425037
22.

Phonotraumatic Injury in Fitness Instructors: Risk Factors, Diagnoses, and Treatment Methods.

Estes C, Sadoughi B, Coleman R, D'Angelo D, Sulica L.

J Voice. 2018 Nov 1. pii: S0892-1997(18)30361-8. doi: 10.1016/j.jvoice.2018.10.001. [Epub ahead of print]

PMID:
30393049
23.

Management and Treatment of Recurrent Epithelial Ovarian Cancer.

Armbruster S, Coleman RL, Rauh-Hain JA.

Hematol Oncol Clin North Am. 2018 Dec;32(6):965-982. doi: 10.1016/j.hoc.2018.07.005. Review.

PMID:
30390768
24.

Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.

Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, Buda A, Yan X, Shuzhong Y, Chetty N, Isla D, Tamura M, Zhu T, Robledo KP, Gebski V, Asher R, Behan V, Nicklin JL, Coleman RL, Obermair A.

N Engl J Med. 2018 Nov 15;379(20):1895-1904. doi: 10.1056/NEJMoa1806395. Epub 2018 Oct 31.

PMID:
30380365
25.

Concordance of a laparoscopic scoring algorithm with primary surgery findings in advanced stage ovarian cancer.

Hansen JM, Sood AK, Coleman RL, Westin SN, Soliman PT, Ramirez PT, Fellman BM, Schmeler KM, Fleming ND.

Gynecol Oncol. 2018 Dec;151(3):428-432. doi: 10.1016/j.ygyno.2018.10.017. Epub 2018 Oct 23.

PMID:
30366647
26.

Simulating the impact of targeting lower systolic blood pressure and LDL-cholesterol levels on type 2 diabetes complication rates.

Mostafa SA, Coleman RL, Agbaje OF, Gray AM, Holman RR, Bethel MA.

J Diabetes Complications. 2019 Jan;33(1):69-74. doi: 10.1016/j.jdiacomp.2018.09.017. Epub 2018 Oct 10.

PMID:
30361000
27.

Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial.

Falchook G, Coleman RL, Roszak A, Behbakht K, Matulonis U, Ray-Coquard I, Sawrycki P, Duska LR, Tew W, Ghamande S, Lesoin A, Schwartz PE, Buscema J, Fabbro M, Lortholary A, Goff B, Kurzrock R, Martin LP, Gray HJ, Fu S, Sheldon-Waniga E, Lin HM, Venkatakrishnan K, Zhou X, Leonard EJ, Schilder RJ.

JAMA Oncol. 2018 Oct 18:e183773. doi: 10.1001/jamaoncol.2018.3773. [Epub ahead of print]

PMID:
30347019
28.

The affinity, intrinsic activity and selectivity of a structurally novel EP2 receptor agonist at human prostanoid receptors.

Coleman RA, Woodrooffe AJ, Clark KL, Toris CB, Fan S, Wang JW, Woodward DF.

Br J Pharmacol. 2019 Mar;176(5):687-698. doi: 10.1111/bph.14525. Epub 2019 Jan 4.

29.

Unilateral Withdrawal of Life-sustaining Therapy in a Severely Impaired Child.

Miller KE, Coleman RD, Eisenberg L, Henriksen J, Lantos JD, Weiss EM.

Pediatrics. 2018 Nov;142(5). pii: e20180131. doi: 10.1542/peds.2018-0131. Epub 2018 Oct 12.

PMID:
30315121
30.

A Sensitive High-Throughput Screening Method for Identifying Small Molecule Stimulators of the Core Particle of the Proteasome.

Coleman RA, Trader DJ.

Curr Protoc Chem Biol. 2018 Dec;10(4):e52. doi: 10.1002/cpch.52. Epub 2018 Oct 4.

PMID:
30285317
31.

Comparing estimates of disability prevalence using federal and international disability measures in national surveillance.

Lauer EA, Henly M, Coleman R.

Disabil Health J. 2018 Sep 13. pii: S1936-6574(18)30183-3. doi: 10.1016/j.dhjo.2018.08.008. [Epub ahead of print]

PMID:
30268508
32.

Circumcision in the paediatric patient: A review of indications, technique and complications.

Prabhakaran S, Ljuhar D, Coleman R, Nataraja RM.

J Paediatr Child Health. 2018 Dec;54(12):1299-1307. doi: 10.1111/jpc.14206. Epub 2018 Sep 23. Review.

PMID:
30246352
33.

A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice.

Jazaeri A, Coleman RL, Sood AK, Frumovitz MM, Soliman PT, Shafer A, Cutrera JJ, Klinger M, Sharafi SE, Johnson CAL, Villanueva VF, Hinchcliff EM, Dickens A, Cain KE, Anderson JE, Lu KH, Westin SN.

Gynecol Oncol. 2018 Nov;151(2):374-380. doi: 10.1016/j.ygyno.2018.08.037. Epub 2018 Sep 10. Review.

PMID:
30213435
34.

The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis.

Truax AD, Chen L, Tam JW, Cheng N, Guo H, Koblansky AA, Chou WC, Wilson JE, Brickey WJ, Petrucelli A, Liu R, Cooper DE, Koenigsknecht MJ, Young VB, Netea MG, Stienstra R, Sartor RB, Montgomery SA, Coleman RA, Ting JP.

Cell Host Microbe. 2018 Sep 12;24(3):364-378.e6. doi: 10.1016/j.chom.2018.08.009.

PMID:
30212649
35.

Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults.

Holland TL, Chambers HF, Boucher HW, Corey GR, Coleman R, Castaneda-Ruiz B, Fowler VG.

Clin Infect Dis. 2019 Feb 15;68(5):865-872. doi: 10.1093/cid/ciy774.

PMID:
30202941
36.

Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer.

Nishio S, Matsuo K, Yonemoto K, Shimokawa M, Hosaka M, Kodama M, Miyake TM, Ushijima K, Kamura T, Westin SN, Soliman PT, Coleman RL.

Oncotarget. 2018 Aug 17;9(64):32321-32330. doi: 10.18632/oncotarget.25962. eCollection 2018 Aug 17.

37.

Long-chain acyl-CoA synthetase 1 interacts with key proteins that activate and direct fatty acids into niche hepatic pathways.

Young PA, Senkal CE, Suchanek AL, Grevengoed TJ, Lin DD, Zhao L, Crunk AE, Klett EL, Füllekrug J, Obeid LM, Coleman RA.

J Biol Chem. 2018 Oct 26;293(43):16724-16740. doi: 10.1074/jbc.RA118.004049. Epub 2018 Sep 6.

PMID:
30190326
38.

Investigation of dried blood sampling with liquid chromatography tandem mass spectrometry to confirm human exposure to nerve agents.

Shaner RL, Coleman RM, Schulze N, Platanitis K, Brown AA, Seymour C, Kaplan P, Perez J, Hamelin EI, Johnson RC.

Anal Chim Acta. 2018 Nov 29;1033:100-107. doi: 10.1016/j.aca.2018.06.049. Epub 2018 Jun 20.

PMID:
30172315
39.

Proteolipid domains form in biomimetic and cardiac mitochondrial vesicles and are regulated by cardiolipin concentration but not monolyso-cardiolipin.

Pennington ER, Sullivan EM, Fix A, Dadoo S, Zeczycki TN, DeSantis A, Schlattner U, Coleman RA, Chicco AJ, Brown DA, Shaikh SR.

J Biol Chem. 2018 Oct 12;293(41):15933-15946. doi: 10.1074/jbc.RA118.004948. Epub 2018 Aug 29.

PMID:
30158245
40.

Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma.

Zibetti Dal Molin G, Abrahão CM, Coleman RL, Maluf FC.

Gynecol Oncol Res Pract. 2018 Aug 18;5:6. doi: 10.1186/s40661-018-0063-3. eCollection 2018.

41.

Comprehensive geriatric assessment and decision-making in older men with incurable but manageable (chronic) cancer.

Handforth C, Burkinshaw R, Freeman J, Brown JE, Snowden JA, Coleman RE, Greenfield DM.

Support Care Cancer. 2018 Aug 25. doi: 10.1007/s00520-018-4410-z. [Epub ahead of print]

PMID:
30143894
42.

Can transplanting enhance mobile marine invertebrates in ecologically engineered rock pools?

Morris RL, Martinez AS, Firth LB, Coleman RA.

Mar Environ Res. 2018 Oct;141:119-127. doi: 10.1016/j.marenvres.2018.08.008. Epub 2018 Aug 13.

PMID:
30131177
43.

Rucaparib in ovarian cancer: extending the use of PARP inhibitors in the recurrent disease.

Dal Molin GZ, Westin SN, Coleman RL.

Future Oncol. 2018 Aug 14. doi: 10.2217/fon-2018-0215. [Epub ahead of print]

PMID:
30105925
44.

Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer.

Fleming ND, Nick AM, Coleman RL, Westin SN, Ramirez PT, Soliman PT, Fellman B, Meyer LA, Schmeler KM, Lu KH, Sood AK.

Obstet Gynecol. 2018 Sep;132(3):545-554. doi: 10.1097/AOG.0000000000002796.

PMID:
30095787
45.

Modulating Bone Marrow Hematopoietic Lineage Potential to Prevent Bone Metastasis in Breast Cancer.

Ubellacker JM, Baryawno N, Severe N, DeCristo MJ, Sceneay J, Hutchinson JN, Haider MT, Rhee CS, Qin Y, Gregory WM, Garrido-Castro AC, Holen I, Brown JE, Coleman RE, Scadden DT, McAllister SS.

Cancer Res. 2018 Sep 15;78(18):5300-5314. doi: 10.1158/0008-5472.CAN-18-0548. Epub 2018 Jul 31.

PMID:
30065048
46.

When Ovarian Cancer Is Not: Characterizing Nonovarian Cancer Pathology in a Laparoscopy-Based Triage System.

Dood RL, Fleming ND, Coleman RL, Westin SN, Lara OD, LaFargue CJ, Liu J, Sood AK.

Int J Gynecol Cancer. 2018 Oct;28(8):1485-1490. doi: 10.1097/IGC.0000000000001329.

PMID:
30036226
47.

Comparison of nine platelet function tests used to determine responses to different aspirin dosages in people with type 2 diabetes.

Harrison P, Bethel MA, Kennedy I, Dinsdale R, Coleman R, Holman RR.

Platelets. 2018 Jul 9:1-9. doi: 10.1080/09537104.2018.1478402. [Epub ahead of print]

PMID:
29985735
48.

Paclitaxel and Pazopanib in Ovarian Cancer-Reply.

Richardson DL, Coleman RL, Sill MW.

JAMA Oncol. 2018 Sep 1;4(9):1299. doi: 10.1001/jamaoncol.2018.1712. No abstract available.

PMID:
29978183
49.

Rucaparib in ovarian cancer: an update on safety, efficacy and place in therapy.

Dal Molin GZ, Omatsu K, Sood AK, Coleman RL.

Ther Adv Med Oncol. 2018 Jun 22;10:1758835918778483. doi: 10.1177/1758835918778483. eCollection 2018. Review.

50.

Transcriptional burst fraction and size dynamics during lens fiber cell differentiation and detailed insights into the denucleation process.

Limi S, Senecal A, Coleman R, Lopez-Jones M, Guo P, Polumbo C, Singer RH, Skoultchi AI, Cvekl A.

J Biol Chem. 2018 Aug 24;293(34):13176-13190. doi: 10.1074/jbc.RA118.001927. Epub 2018 Jun 29.

PMID:
29959226

Supplemental Content

Loading ...
Support Center